| Author/Editor | Fleischmann, W Robert Jr; Koren, Srečko | |
| Title | Systemic effects of orally administered interferons and interleukin-2 | |
| Type | članek | |
| Source | J Interferon Cytokine Res | |
| Vol. and No. | Letnik 19 | |
| Publication year | 1999 | |
| Volume | str. 829-39 | |
| Language | eng | |
| Abstract | Orally administered interferons (IFN-alpha, IFN-beta, and IFN-gamma) have been shown to exert a number of systemic effects. Orally administered IFNs exert dose-dependent suppressive effects on the peripheral white blood cell (WBC) count. The suppression of the peripheral WBC count is mediated by a suppression of the function of the borie marrow, as measured in an in vitro bone marrow colony-forming assay. The peripheral WBC and bone marrow suppressive effects of orally administered IFNs are at least as potent as those occurring with parenterally administered IFNs. However, the mechanism by which orally administered IFNs exert these peripheral WBC suppressive and bone marrow suppressive effects differs significantly from that of parenterally administered IFNs: orally administered IFN is not detectable in the serum, the effect of orally administered IFN is not blocked by circulating antibody, the effect of orally administered IFN can be adoptively transferred by injection with peripheral white blood cells from donor mice, and the effect of orally administered IFN develops more slowly than that of parenterally administered interferon. Orally administered IFN-alpha employed alone and in synergistic combination with intraperitoneally administered IFN-gamma can exert an antitumor effect. Finally, orally administered inferleukin-2 can exert a suppressive effect on both the peripheral white blood cell count and on the bone marrow. These observations suggest that the oral route may be an effective and novel mechanism for the efficacious administration of IFNs and other lymphokines/cytokines. | |
| Descriptors | INTERFERONS INTERLEUKIN-2 ADMINISTRATION, ORAL BONE MARROW MICE COLONY-FORMING UNITS ASSAY IMMUNOSUPPRESSION LEUKOCYTE COUNT INTERFERON-ALPHA INTERFERON-BETA INTERFERON TYPE II |